Autopsy report · NCT00940641

Assess the Absorption, Distribution, Metabolism and Excretion of AZD7325 After Intravenous and Oral Administration

“Study withdrawn prior to enrollment due to AZ business decision unrelated to safety.”

The sponsor’s own words in the registry.

Life of this trial

• Suspended: paused, and may or may not restart.
• 8 participants planned (an estimate, not an actual count).

Vital statistics

Status

Suspended

Phase

Phase 1

Sponsor

AstraZeneca

Sponsor type

Industry

Conditions

Absorption; Distribution; Metabolism; Excretion

Interventions

AZD7325; AZD7325

Participants

8 (planned, not actual)

Sites

1

Countries

United Kingdom

Trials that died the same way

• EPIC- Extracorporeal Photopheresis (ECP) for Immune-related Colitis
  “Study Withdrawn by Sponsor prior to Enrollment.” (75% match in meaning)
• A Study of Glucose Control in Participants With Type 1 and Type 2 Diabetes
  “Study was withdrawn prior to enrolment due to business decision.” (74% match in meaning)
• Effects of AffronEye®/ Crocuvis+® on Dry Eye Syndrome
  “Study withdrawn prior to enrollment due to sponsor decision” (73% match in meaning)
• A Study of the Safety and Efficacy of Pancreatic Endocrine Cell Clusters Implanted Into the Omentum of Type 1 Diabetes Patients With Severe Hypoglycemia
  “Study is being withdrawn for business reasons” (71% match in meaning)
• Dose Ranging Study to Evaluate the Efficacy and Safety of MEDI8852 in Adults Who Are Hospitalized With Type A Influenza.
  “Study is withdrawn due to company decision.” (71% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.